Knee OA. Arthrosis, unspecified
Conditions
Interventions
Intervention 1: Corticosteroide injection in knee:40mg triamsinolon for the Daroupakhsh company injected intraarticular. Intervention 2: Intraarticular injection PRP-40 cc of patients blood centrif
Treatment - Drugs
Corticosteroide injection in knee:40mg triamsinolon for the Daroupakhsh company injected intraarticular
Intraarticular injection PRP-40 cc of patients blood centrifuged,finally 10 cc PRP produced
Sponsors
Vice chancellor for research of Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age30-75years old; ASA class 2-3 exclusion criteria: Patient dissatisfaction
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patiet pain. Timepoint: In times before injection every 4 weeks to 3 months and 3months after treatment. Method of measurement: Based on the OKS(oxford knee score) and VAS(visual analoge scale). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahram Naderi nabi
Guilan University of Medical Sciences
Outcome results
None listed